4.6 Article

The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease

Related references

Note: Only part of the references are listed.
Article Neurosciences

Development of Apathy, Anxiety, and Depression in Cognitively Unimpaired Older Adults: Effects of Alzheimer's Disease Pathology and Cognitive Decline

Maurits Johansson et al.

Summary: This study found that AD pathology in early stages of the disease is associated with the development of apathy and anxiety, independent of cognitive changes. The effects of A beta pathology on apathy are partially mediated by changes in cognitive performance.

BIOLOGICAL PSYCHIATRY (2022)

News Item Clinical Neurology

Disease modification is not all - we need symptomatic therapies for Alzheimer disease

Jeffrey Cummings

Summary: A new study has found methylphenidate to be effective in treating apathy in individuals with Alzheimer's disease, highlighting the importance of developing better symptomatic treatment options for this population in light of recent aducanumab approval focusing on disease-modifying therapies.

NATURE REVIEWS NEUROLOGY (2022)

Article Geriatrics & Gerontology

Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials

Moyra E. Mortby et al.

Summary: Apathy is a prevalent and persistent neuropsychiatric symptom in neurocognitive disorders, and recent advances in understanding and intervention highlight its importance. Progress has been made in understanding apathy as a treatment target, but further research is needed in areas such as diagnostic procedures, symptom measurement, biological mechanisms, and treatment strategies. Advancing the understanding of apathy's subdomains and biological mechanisms will promote its role as a treatment target in clinical trials.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2022)

Article Clinical Neurology

Accelerated atrophy in dopaminergic targets and medial temporo-parietal regions precedes the onset of delusions in patients with Alzheimer's disease

Riccardo Manca et al.

Summary: People with Alzheimer's disease who develop delusions have worse prognosis and decline in episodic memory and grey matter volume in specific brain regions compared to those who do not develop delusions.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE (2022)

Article Neurosciences

Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model

Elena Spoleti et al.

Summary: This study reveals that impaired cell excitability and firing in ventral CA1 pyramidal neurons is an early feature in Tg2576 AD mice.

EXPERIMENTAL NEUROLOGY (2022)

Article Multidisciplinary Sciences

Amyloid-β impairs mitochondrial dynamics and autophagy in Alzheimer's disease experimental models

Macarena de la Cueva et al.

Summary: The amyloid cascade hypothesis is the most accepted hypothesis in Alzheimer's disease, suggesting that the accumulation of A beta protein may trigger the development of the disease. This accumulation may occur years before clinical symptoms, but it is unclear whether it is the cause or consequence of AD. However, it is known that the accumulation of A beta protein has toxic effects on brain cells. Therefore, it is important to study all possible events associated with this accumulation in order to develop new therapeutic strategies. The dysfunction of mitochondria could be an early feature of AD, associated with amyloid overload.

SCIENTIFIC REPORTS (2022)

Article Geriatrics & Gerontology

Structural Brain Differences Between Cognitively Impaired Patients With and Without Apathy

Nathan K. Chan et al.

Summary: The study found that thinner right medial orbitofrontal and left rostral anterior cingulate cortices, and thicker left middle temporal cortices were associated with apathy in cognitively impaired individuals.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2021)

Article Geriatrics & Gerontology

The association among apathy, leisure activity participation, and severity of dementia in nursing home residents with Alzheimer's disease: A cross-sectional study

Yi Yang et al.

Summary: Leisure activity participation is negatively associated with apathy, while the severity of dementia is positively associated with apathy. The severity of dementia moderates the effect of leisure activity participation on apathy.

GERIATRIC NURSING (2021)

Article Neurosciences

Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease

Livia La Barbera et al.

Summary: Recent studies suggest that degeneration of dopaminergic neurons in the Ventral Tegmental Area could be one of the first events in Alzheimer's Disease. Using a mouse model, researchers found that treatment with Nilotinib could reduce phosphorylation of c-Abl, improve autophagy, lower A beta levels, and prevent degeneration of dopaminergic neurons in the VTA. The drug also preserved dopamine outflow to the hippocampus and improved hippocampal-related cognitive functions.

PROGRESS IN NEUROBIOLOGY (2021)

Article Multidisciplinary Sciences

Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from 18F-FDG PET brain persistent homology network

Tun-Wei Hsu et al.

Summary: Dementia is associated with cellular accumulation and neurotransmitter deficiencies, and PHN analysis can be utilized to track neurochemical network evolution in patients at different stages of dementia.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

Dopaminergic dysfunction in the 3xTg-AD mice model of Alzheimer's disease

Yesica Gloria et al.

Summary: This study identified early dopaminergic dysfunction in a mouse model of AD, suggesting potential consequences for behavior and cognitive function, and providing insights into future therapeutic strategies.

SCIENTIFIC REPORTS (2021)

Article Clinical Neurology

In vivo human molecular neuroimaging of dopaminergic vulnerability along the Alzheimer's disease phases

Arianna Sala et al.

Summary: The study found significant reductions in [123I]FP-CIT binding in both AD-MCI and AD-D patients compared to controls, particularly in the major targets of the ventrotegmental-mesocorticolimbic pathway. Molecular connectivity assessment revealed a widespread loss of inter-connections among subcortical and cortical targets of the mesocorticolimbic network only, highlighting potential therapeutic strategies for AD.

ALZHEIMERS RESEARCH & THERAPY (2021)

Article Geriatrics & Gerontology

Neuropsychiatric symptoms in early stage of Alzheimer's and non-Alzheimer's dementia, and the risk of progression to severe dementia

Tau Ming Liew

Summary: Neuropsychiatric symptoms (NPSs) in early dementia are associated with the risk of progression to severe dementia, particularly in Alzheimer's disease (AD) patients. Different NPSs show varying levels of association with disease progression, with seven symptoms in AD and only hallucinations and delusions in non-AD demonstrating a significant relationship.

AGE AND AGEING (2021)

Article Clinical Neurology

Diagnostic criteria for apathy in neurocognitive disorders

David S. Miller et al.

Summary: This study proposed diagnostic criteria for apathy in neurocognitive disorders, including symptoms persisting or frequently recurring for at least 4 weeks, a change from the patient's usual behavior, causing significant functional impairment, etc.

ALZHEIMERS & DEMENTIA (2021)

Article Clinical Neurology

Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease The ADMET 2 Randomized Clinical Trial

Jacobo Mintzer et al.

Summary: Apathy, characterized by diminished will or initiative, is one of the most prevalent neuropsychiatric symptoms in individuals with Alzheimer disease. A multicenter clinical trial showed that methylphenidate is an effective and safe medication for treating apathy in Alzheimer disease.

JAMA NEUROLOGY (2021)

Article Psychiatry

Prefrontal Aβ pathology influencing the pathway from apathy to cognitive decline in non-dementia elderly

Lin Sun et al.

Summary: This study found that apathy syndrome is closely related to cognitive decline and increased Aβ burden. Aβ pathology mediates the effects of apathy on cognitive function and quality of life, while prefrontal Aβ pathology influences the pathway from apathy to cognitive decline.

TRANSLATIONAL PSYCHIATRY (2021)

Review Psychiatry

Impact of Early Life Stress on Reward Circuit Function and Regulation

Jamie L. Hanson et al.

Summary: Early life stress increases the risk of mood, anxiety, and substance use disorders throughout one's lifetime, mainly through changes in motivation and reward processing in the reward circuit. Research indicates that early life stress impacts the structure and function of the reward circuit.

FRONTIERS IN PSYCHIATRY (2021)

Article Neurosciences

Ventral Tegmental Area Disconnection Contributes Two Years Early to Correctly Classify Patients Converted to Alzheimer's Disease: Implications for Treatment

Laura Serra et al.

Summary: This study longitudinally investigated VTA disconnection in predicting conversion to AD in a cohort of MCI-AD patients. Results showed that converters exhibited significant reduction of VTA-driven connectivity compared to non-converters, which remained consistent at 24-month follow-up. These findings suggest potential implications for AD staging and prognosis, and support new opportunities for therapeutic interventions.

JOURNAL OF ALZHEIMERS DISEASE (2021)

Article Neurosciences

Nicotine inhibits the VTA-to-amygdala dopamine pathway to promote anxiety

Claire Nguyen et al.

Summary: Nicotine affects dopamine neurons in the ventral tegmental area, eliciting opposite functional responses in different populations of neurons projecting to different brain regions, leading to anxiety-like behavior.

NEURON (2021)

Article Medicine, General & Internal

Trial of Pimavanserin in Dementia-Related Psychosis

Pierre N. Tariot et al.

Summary: Pimavanserin shows efficacy in reducing psychosis in patients with dementia-related to neurodegenerative diseases. Results of a randomized discontinuation trial indicate that the relapse rate over 26 weeks is 13% with pimavanserin and 28% with placebo. Further research is needed to determine the long-term effects of pimavanserin in dementia-related psychosis.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Neurosciences

Mesocorticolimbic Dopamine Pathways Across Adolescence: Diversity in Development

Lauren M. Reynolds et al.

Summary: The development of mesocorticolimbic dopamine circuitry during adolescence is gradual and establishes stable adult levels of behavioral functioning, yet also makes them vulnerable to environmental perturbations. Recent studies have focused on understanding the mechanisms underlying dopamine pathway development in the adolescent brain and how the environment influences these processes, integrating them into a historical framework of anatomical and neurochemical changes in this system.

FRONTIERS IN NEURAL CIRCUITS (2021)

Article Clinical Neurology

Alzheimer's disease drug development pipeline: 2021

Jeffrey Cummings et al.

Summary: Overall, the study highlights the urgent need for new treatments for Alzheimer's disease, and shows that a diverse range of drugs targeting the biology of AD are being explored in clinical trials. Biomedical biomarkers are also being increasingly used in these trials to assess effectiveness.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)

Article Clinical Neurology

Rasagiline effects on glucose metabolism, cognition, and tau in Alzheimer's dementia

Dawn C. Matthews et al.

Summary: The study showed that rasagiline may have benefits on clinical and neuroimaging measures in patients with mild to moderate Alzheimer's disease. It appears to affect neuronal activity in frontostriatal pathways, with promising clinical outcomes that warrant further investigation in a larger trial. The use of biomarkers to characterize patients and detect treatment response also showed potential benefits in therapeutic repurposing.

ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)

Review Geriatrics & Gerontology

Depression, Anxiety, and Apathy in Mild Cognitive Impairment: Current Perspectives

Lina Ma

FRONTIERS IN AGING NEUROSCIENCE (2020)

Article Neurosciences

In vivo MRI Structural and PET Metabolic Connectivity Study of Dopamine Pathways in Alzheimer's Disease

Leonardo Iaccarino et al.

JOURNAL OF ALZHEIMERS DISEASE (2020)

Article Multidisciplinary Sciences

Reduced monoaminergic nuclei MRI signal detectable in pre-symptomatic older adults with future memory decline

Annalena Venneri et al.

SCIENTIFIC REPORTS (2020)

Article Clinical Neurology

Apathy in Alzheimer's Disease Correlates with the Dopamine Transporter Level in the Caudate Nuclei

Niki Udo et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2020)

Editorial Material Neurosciences

Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease

Paraskevi Krashia et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)

Review Psychology, Clinical

Prevalence, neurobiology, and treatments for apathy in prodromal dementia

Chelsea Sherman et al.

INTERNATIONAL PSYCHOGERIATRICS (2018)

Article Behavioral Sciences

The anatomy of apathy: A neurocognitive framework for amotivated behaviour

C. Le Heron et al.

NEUROPSYCHOLOGIA (2018)

Editorial Material Neurosciences

Ventral Tegmental Area in Prodromal Alzheimer's Disease: Bridging the Gap between Mice and Humans

Marcello D'Amelio et al.

JOURNAL OF ALZHEIMERS DISEASE (2018)

Article Biochemistry & Molecular Biology

Pattern of tyrosine hydroxylase expression during aging of mesolimbic pathway of the rat

Bianca Norrara et al.

JOURNAL OF CHEMICAL NEUROANATOMY (2018)

Review Pharmacology & Pharmacy

The role of dopaminergic midbrain in Alzheimer's disease: Translating basic science into clinical practice

Marcello D'Amelio et al.

PHARMACOLOGICAL RESEARCH (2018)

Article Geriatrics & Gerontology

In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer's disease

Laura Serra et al.

NEUROBIOLOGY OF AGING (2018)

Article Neurosciences

On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area

Paraskevi Krashia et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2017)

Article Geriatrics & Gerontology

Patterns and persistence of behavioural and psychological symptoms in those with cognitive impairment: the importance of apathy

Rianne M. van der Linde et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2017)

Article Neurosciences

Neuropsychiatric Symptoms and Cognitive Impairment: Understanding the Importance of Co-Morbid Symptoms

Moyra E. Mortby et al.

JOURNAL OF ALZHEIMERS DISEASE (2017)

Article Geriatrics & Gerontology

Apathy: Risk Factor for Mortality in Nursing Home Patients

Johanna M. H. Nijsten et al.

JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2017)

Review Neurosciences

Ventral tegmental area: cellular heterogeneity, connectivity and behaviour

Marisela Morales et al.

NATURE REVIEWS NEUROSCIENCE (2017)

Article Multidisciplinary Sciences

Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease

Annalisa Nobili et al.

NATURE COMMUNICATIONS (2017)

Review Clinical Neurology

Apathy associated with neurocognitive disorders: Recent progress and future directions

Krista L. Lanctot et al.

ALZHEIMERS & DEMENTIA (2017)

Article Geriatrics & Gerontology

Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease

Jennifer R. Gatchel et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2017)

Article Geriatrics & Gerontology

Mood Changes in Cognitively Normal Older Adults are Linked to Alzheimer Disease Biomarker Levels

Ganesh M. Babulal et al.

AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2016)

Article Clinical Neurology

The prevalence of neuropsychiatric symptoms in Alzheimer's disease: Systematic review and meta-analysis

Qing-Fei Zhao et al.

JOURNAL OF AFFECTIVE DISORDERS (2016)

Review Multidisciplinary Sciences

The road to restoring neural circuits for the treatment of Alzheimer's disease

Rebecca G. Canter et al.

NATURE (2016)

Article Biochemistry & Molecular Biology

Circuit Architecture of VTA Dopamine Neurons Revealed by Systematic Input-Output Mapping

Kevin T. Beier et al.

Review Neurosciences

Stress effects on the neural substrates of motivated behavior

Nick G. Hollon et al.

NATURE NEUROSCIENCE (2015)

Article Neurosciences

Midbrain dopamine neurons bidirectionally regulate CA3-CA1 synaptic drive

Zev B. Rosen et al.

NATURE NEUROSCIENCE (2015)

Article Geriatrics & Gerontology

Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study

Julien Delrieu et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2015)

Review Behavioral Sciences

Progress in understanding mood disorders: optogenetic dissection of neural circuits

S. Lammel et al.

GENES BRAIN AND BEHAVIOR (2014)

Review Psychology, Clinical

A review of neuroimaging findings of apathy in Alzheimer's disease

Christos Theleritis et al.

INTERNATIONAL PSYCHOGERIATRICS (2014)

Article Neurosciences

Dopaminergic neurons promote hippocampal reactivation and spatial memory persistence

Colin G. McNamara et al.

NATURE NEUROSCIENCE (2014)

Article Neurosciences

Medial prefrontal D1 dopamine neurons control food intake

Benjamin B. Land et al.

NATURE NEUROSCIENCE (2014)

Review Neurosciences

Reward and aversion in a heterogeneous midbrain dopamine system

Stephan Lammel et al.

NEUROPHARMACOLOGY (2014)

Article Neurosciences

Dopaminergic Modulation of Cortical Plasticity in Alzheimer's Disease Patients

Giacomo Koch et al.

NEUROPSYCHOPHARMACOLOGY (2014)

Review Geriatrics & Gerontology

Is dopamine involved in Alzheimer's disease?

Alessandro Martorana et al.

FRONTIERS IN AGING NEUROSCIENCE (2014)

Article Psychology, Clinical

Safety and Efficacy of Methylphenidate for Apathy in Alzheimer's Disease: A Randomized, Placebo-Controlled Trial

Paul B. Rosenberg et al.

JOURNAL OF CLINICAL PSYCHIATRY (2013)

Article Multidisciplinary Sciences

Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons

Dipesh Chaudhury et al.

NATURE (2013)

Review Neurosciences

The brain reward circuitry in mood disorders

Scott J. Russo et al.

NATURE REVIEWS NEUROSCIENCE (2013)

Article Biochemistry & Molecular Biology

Selegiline Reverses Aβ25-35-Induced Cognitive Deficit in Male Mice

Andreia M. Pazini et al.

NEUROCHEMICAL RESEARCH (2013)

Review Behavioral Sciences

Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care

Ludwig Trillo et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2013)

Article Psychology, Clinical

Anxiety is related to Alzheimer cerebrospinal fluid markers in subjects with mild cognitive impairment

I. H. G. B. Ramakers et al.

PSYCHOLOGICAL MEDICINE (2013)

Review Neurosciences

Dissecting the diversity of midbrain dopamine neurons

Jochen Roeper

TRENDS IN NEUROSCIENCES (2013)

Article

Midlife vs Late-Life Depressive Symptoms and Risk of Dementia

Kristine Yaffe

ARCHIVES OF GENERAL PSYCHIATRY (2012)

Review Neurosciences

Mouse models of Alzheimer's disease

Alicia M. Hall et al.

BRAIN RESEARCH BULLETIN (2012)

Article Geriatrics & Gerontology

Apathy: Prevalence, Associated Factors, and Prognostic Value Among Frail, Older Inpatients

Eeva H. Holtta et al.

JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION (2012)

Review Neurosciences

The Mysterious Motivational Functions of Mesolimbic Dopamine

John D. Salamone et al.

NEURON (2012)

Article Multidisciplinary Sciences

Prefrontal D1 dopamine signaling is required for temporal control

Nandakumar S. Narayanan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Clinical Neurology

The pathological process underlying Alzheimer's disease in individuals under thirty

Heiko Braak et al.

ACTA NEUROPATHOLOGICA (2011)

Article Clinical Neurology

Neuropsychiatric symptoms in Alzheimer’s disease

Constantine G. Lyketsos et al.

Alzheimers & Dementia (2011)

Article Clinical Neurology

Apomorphine Treatment in Alzheimer Mice Promoting Amyloid-β Degradation

Eri Himeno et al.

ANNALS OF NEUROLOGY (2011)

Article Clinical Neurology

Altered dopamine modulation of LTD-like plasticity in Alzheimer's disease patients

Giacomo Koch et al.

CLINICAL NEUROPHYSIOLOGY (2011)

Article Biochemistry & Molecular Biology

Activation of D1/D5 Dopamine Receptors Protects Neurons from Synapse Dysfunction Induced by Amyloid-β Oligomers

Sofia Juergensen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Clinical Neurology

Regional brain atrophy and functional disconnection across Alzheimer's disease evolution

T. Gili et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)

Article Neurosciences

Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease

Marcello D'Amelio et al.

NATURE NEUROSCIENCE (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand F-18-AV-45 (Flobetapir F 18)

Dean F. Wong et al.

JOURNAL OF NUCLEAR MEDICINE (2010)

Review Neurosciences

Dopamine in Motivational Control: Rewarding, Aversive, and Alerting

Ethan S. Bromberg-Martin et al.

NEURON (2010)

Review Neurosciences

Cortico-Basal Ganglia Reward Network: Microcircuitry

Susan R. Sesack et al.

NEUROPSYCHOPHARMACOLOGY (2010)

Review Behavioral Sciences

Linking cognitive aging to alterations in dopamine neurotransmitter functioning: Recent data and future avenues

Lars Backman et al.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)

Article Geriatrics & Gerontology

Levodopa ameliorates learning and memory deficits in a murine model of Alzheimer's disease

Oliver Ambree et al.

NEUROBIOLOGY OF AGING (2009)

Article Multidisciplinary Sciences

Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli

Frederic Brischoux et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Multidisciplinary Sciences

Phasic Firing in Dopaminergic Neurons Is Sufficient for Behavioral Conditioning

Hsing-Chen Tsai et al.

SCIENCE (2009)

Review Clinical Neurology

Behavioral effects of current Alzheimer's disease treatments: A descriptive review

Jeffrey L. Cummings et al.

ALZHEIMERS & DEMENTIA (2008)

Article Behavioral Sciences

Synergistic effects of selegiline and donepezil on cognitive impairment induced by amyloid beta (25-35)

Hiroko Tsunekawa et al.

BEHAVIOURAL BRAIN RESEARCH (2008)

Article Geriatrics & Gerontology

Neuropsychiatric correlates of cerebrospinal fluid biomarkers in Alzheimer's disease

Ragnhild Skogseth et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2008)

Article Geriatrics & Gerontology

The MRI brain correlates of depressed mood, anhedonia, apathy, and anergia in older adults with and without cognitive impairment or dementia

Helen Lavretsky et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2008)

Article Geriatrics & Gerontology

PET imaging of amyloid deposition in patients with mild cognitive impairment

Anton Forsberg et al.

NEUROBIOLOGY OF AGING (2008)

Review Neurosciences

Dopamine neuron systems in the brain:: an update

Anders Bjorklund et al.

TRENDS IN NEUROSCIENCES (2007)

Review Neurosciences

Regulation of firing of dopaminergic neurons and control of goal-directed behaviors

Anthony A. Grace et al.

TRENDS IN NEUROSCIENCES (2007)

Article Clinical Neurology

Tau and α-synuclein brainstem pathology in Alzheimer disease:: relation with extrapyramidal signs

Johannes Attems et al.

ACTA NEUROPATHOLOGICA (2007)

Review Medicine, General & Internal

Alzheimer's disease

Kaj Blennow et al.

LANCET (2006)

Article Multidisciplinary Sciences

Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease

JS Jacobsen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Medicine, General & Internal

Pharmacological treatment of neuropsychiatric symptoms of dementia - A review of the evidence

KM Sink et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Article Clinical Neurology

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

WE Klunk et al.

ANNALS OF NEUROLOGY (2004)

Article Neurosciences

Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease

N Kemppainen et al.

EUROPEAN JOURNAL OF NEUROSCIENCE (2003)

Review Neurosciences

Getting formal with dopamine and reward

W Schultz

NEURON (2002)

Article Neurosciences

The relationship between A beta and memory in the Tg2576 mouse model of Alzheimer's disease

MA Westerman et al.

JOURNAL OF NEUROSCIENCE (2002)